Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
123.10
+1.50 (1.23%)
Aug 14, 2025, 3:10 PM AST

TADAWUL:4016 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
432.07394338.44302.66287.22301.66
Revenue Growth (YoY)
17.77%16.42%11.82%5.38%-4.79%-
Cost of Revenue
164.79151.59134.74119.21113.47126.25
Gross Profit
267.28242.41203.7183.45173.76175.41
Selling, General & Admin
160.24150127.59113.7397.7492.87
Other Operating Expenses
-0.14-0.420.090.18-0.140.05
Operating Expenses
163.67153.12126.17114.0497.694.92
Operating Income
103.6189.2977.5369.4176.1680.49
Interest Expense
-4.42-3.67-5.75-4.73-1.87-1.2
Currency Exchange Gain (Loss)
-0.04-0.04-0.470.27--
Other Non Operating Income (Expenses)
-----1.08-1.48
EBT Excluding Unusual Items
99.1485.5871.3164.9573.2277.81
Gain (Loss) on Sale of Investments
-----2.76-
Gain (Loss) on Sale of Assets
0.120.120.130.08--
Pretax Income
99.9186.3571.4465.0270.4677.81
Income Tax Expense
7.036.55.615.574.185
Net Income
92.8879.8565.8359.4566.2872.81
Net Income to Common
92.8879.8565.8359.4566.2872.81
Net Income Growth
16.90%21.30%10.72%-10.31%-8.97%-
Shares Outstanding (Basic)
202020202020
Shares Outstanding (Diluted)
202020202020
EPS (Basic)
4.643.993.292.973.313.64
EPS (Diluted)
4.643.993.292.973.313.64
EPS Growth
16.89%21.30%10.72%-10.31%-8.97%-
Free Cash Flow
28.5624.1371.8258.9925.2811.42
Free Cash Flow Per Share
1.431.213.592.951.260.57
Dividend Per Share
1.2502.000----
Gross Margin
61.86%61.52%60.19%60.61%60.50%58.15%
Operating Margin
23.98%22.66%22.91%22.93%26.52%26.68%
Profit Margin
21.50%20.27%19.45%19.64%23.08%24.14%
Free Cash Flow Margin
6.61%6.12%21.22%19.49%8.80%3.79%
EBITDA
118.8699.0885.1476.2582.8687.19
EBITDA Margin
27.51%25.15%25.16%25.19%28.85%28.90%
D&A For EBITDA
15.269.87.616.846.76.69
EBIT
103.6189.2977.5369.4176.1680.49
EBIT Margin
23.98%22.66%22.91%22.93%26.52%26.68%
Effective Tax Rate
7.04%7.53%7.85%8.57%5.93%6.43%
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.